EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY-NC 4.0

Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression

Patricia Andrews, Jennifer N Vega, Sarah M Szymkowicz, Paul Newhouse, Rachel Tyndale, Damian Elson, Hakmook Kang, Sarah Siddiqi, Elizabeth B Tyner, Kathleen Mather, Faith M Gunning, Warren D Taylor

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2024.07.025 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Patricia Andrews und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Affect, Antidepressive Agents, Executive Function, Nicotine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, NCATS NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AffectAntidepressive AgentsExecutive FunctionNicotineAgedFemaleHumansMaleMiddle AgedAdministration, CutaneousDepressionDrug Therapy, CombinationTobacco Use Cessation DevicesTreatment Outcome

Stichwörter der Autor:innen

AcetylcholineClinical trialDepressionExecutive functionGeriatricsNicotine

Substanzen

Antidepressive AgentsNicotine

Autor:innen und Institutionen

  • Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA; Geriatric Research, Education, and Clinical Center, Veterans Affairs Tennessee Va…
  • Departments of Pharmacology, Toxicology, and Psychiatry, University of Toronto, and the Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, New York, NY, USA.

Förderung

  • NIMH NIH HHS
  • NCATS NIH HHS
  • National Institute of Mental Health
  • National Institutes of Health
  • American Association for Geriatric Psychiatry
  • National Center for Advancing Translational Sciences

Zitieren

APA

Andrews, P., Vega, J. N., Szymkowicz, S. M., Newhouse, P., Tyndale, R., Elson, D., Kang, H., Siddiqi, S., Tyner, E. B., Mather, K., Gunning, F. M., & Taylor, W. D. (2024). Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.07.025

Vancouver

Andrews P, Vega JN, Szymkowicz SM, Newhouse P, Tyndale R, Elson D, et al. Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.07.025

BibTeX
@article{Andrews2024,
  author = {Andrews, Patricia and Vega, Jennifer N and Szymkowicz, Sarah M and Newhouse, Paul and Tyndale, Rachel and Elson, Damian and Kang, Hakmook and Siddiqi, Sarah and Tyner, Elizabeth B and Mather, Kathleen and Gunning, Faith M and Taylor, Warren D},
  title = {Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.07.025}
}
Kostenlos starten →